App Store

Google Play

DK - Details page - Device banner - 894x1036

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

Lyt når som helst, hvor som helst 

CNBC

CNBC’s “Squawk on the Street” with Carl Quintanilla, Jim Cramer and David Faber is broadcast from the floor of the New York Stock Exchange, on site at the opening bell with the up-to-the-minute news investors need to know and interviews with the most influential Chief Executive Officers and greatest market minds.

Squawk on the Street

David Faber, Sara Eisen, and Carl Quintanilla broke down the latest for stocks ahead of a fresh inflation read later this week – and as a number of Wall Street firms raised their 2025 S&P targets (including Barclays, whose defense of that call is featured within the hour). A key focus? How the consumer’s holding up – and how tariffs could impact spending and the path for rates, with Moody’s Chief Economist arguing it could be a challenging year ahead. That said – another report says rising crypto prices could provide a big tailwind to retailers this holiday season, we’ll explain. 

 

Another key part of today’s broadcast: big tech and what to do with Nvidia shares, as the company faces new scrutiny from Chinese antitrust regulators. The team also caught up with the author of a new deep-dive on the company, “The Nvidia Way: Jensen Huang and the Making of a Tech Giant” to discuss how to spot the next trillion dollar opportunity. 

 

Also in focus: Hershey/Mondelez look at a potential deal, Trump’s “Golden Cabinet”, and a new call on Bank of America

 

Squawk on the Street Disclaimer

SOTS 2nd Hour: The Nvidia Way, 2025 S&P Targets, and A Crypto Christmas 12/9/24

Carl Quintanilla, Jim Cramer and David Faber explored what to make of Wall Street firms' price target hiking parade, with the S&P 500 and Nasdaq at record highs.

Hear what Jim said about the catalysts driving the parabolic moves in stocks such as Applovin and Palantir. The anchors also discussed China regulators investigating Nvidia 

over possible violations of the country's anti-monopoly law. Also in focus: Bytedance vs. the law that would force a sale or ban of TikTok in the U.S., what President-elect Trump 

told NBC News, the Omnicom-Interpublic merger deal to create the world's largest ad agency, Apollo and Workday to enter the S&P 500, why Deutsche Bank named Tesla a "Top Pick" for 2025.

 

Squawk on the Street Disclaimer

Record Highs and Parabolic Stocks, China Investigates Nvidia, Ad Giants' Megamerger Deal 12/9/24

Jim and Jeff discuss Nvidia after a regulator in China said it was investigating the chipmaker over possible violations of the country’s antimonopoly law. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake

CNBC Investing Club Disclaimer

Cramer's Morning Take: Nvidia Probe 12/9/24

Carl Quintanilla, Jim Cramer and David Faber led off the show with reaction to shares of Oracle down sharply on a fiscal second-quarter miss and weaker-than-expected guidance.

The anchors also discussed why Morgan Stanley analyst Adam Jonas raised his price target on Tesla to $400 and reiterated the stock's "Top Pick" status. 

Also in focus: Alphabet shares jump on Google's quantum computing chip, a look at OpenAI's new "Sora" AI video generation model, Boeing reportedly restarts 737 MAX production, 

Alaska Air soars, a sneak peek at "Cities of Success: Salt Lake City" which premieres Tuesday night on CNBC at 10pm ET/PT.

 

Squawk on the Street Disclaimer

Oracle Slides, Morgan Stanley's Jonas Ups Tesla PT to $400, Google's "Quantum" Leap 12/10/24

David Faber, Sara Eisen, and Carl Quintanilla discussed the latest for stocks - and the playbook for 2025 with Citi and Evercore’s Chief Equity Strategists. A key debate? Whether the market is over-estimating the odds for rate cuts, given so much positive data and strong earnings commentary. We break down both sides of the argument, and where to put your money to work. 

 

Also in focus: Alaska shares on pace for their best day in years after new guidance – their CEO joined the team to break down the road ahead; Plus what to do with Oracle shares, as they slump on disappointing results there, and a deep dive into Amazon’s burgeoning drone program. 

 

Squawk on the Street Disclaimer

SOTS 2nd Hour: Alaska Flies Higher, The Playbook For 2025, and Odds of a Pause or Pivot 12/10/24

Cramer says it’s worth it to trim holdings of this tech giant. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake 

CNBC Investing Club Disclaimer

Cramer's Morning Take: Alphabet 12/10/24

Carl Quintanilla, Jim Cramer and David Faber explored market reaction to November CPI ahead of next week's Fed decision on interest rates.

Albertsons called off its planned merger with Kroger and filed suit against the company for breach of contract, after federal and state judges blocked

their deal. A CEO doubleheader at Post 9: GE Vernova's Scott Strazik discussed his company's outlook after seeing shares skyrocket since April, when it was spun off by

General Electric. Southwest's Bob Jordan spoke about everything from the airline's 2025 outlook to board changes sparked by activism. 

Also in focus: President-elect Trump picks Andrew Ferguson to chair the FTC, Walgreens reportedly in talks to be taken private, Nasdaq's march toward 20,000.

 

Squawk on the Street Disclaimer

CPI/Inflation Watch, Albertsons Terminates Kroger Merger, GE Vernova and Southwest CEOs 12/11/24

Carl Quintanilla, Sara Eisen and David Faber began the show by breaking down the latest CPI print. Consumers saw inflation pick up slightly in November, as price increases in categories like groceries, gasoline and new cars outweighed a deceleration in others like shelter during the month. The desk also discussed Albertsons terminating its merger agreement with Kroger, while also filing a suit for breach of contract. Also in the mix: mega-cap tech names continued to hit new highs, with Apple also releasing its long-awaited ChatGPT integration with Siri.

 

Squawk on the Street Disclaimer

SOTS 2nd Hour: Nov. CPI Print, Grocery Deal Denied, Apple's AI Strategy, 12/11/24

Cramer says he’s encouraged by this tech stock’s AI roadmap. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake 

CNBC Investing Club Disclaimer

Cramer's Morning Take: Apple 12/11/24

Carl Quintanilla, Sara Eisen, and David Faber discussed a historic morning at the New York Stock Exchange: president-elect Trump ringing the opening bell, walking the floor, and speaking with our own Jim Cramer after being named Time Magazine’s “Person of the Year”. NBC News’ Presidential Historian calling it a “very rare kind of appearance”, while Wharton’s Jeremy Siegel focused on Trump’s growth plans. The team also caught up with NYSE President Lynn Martin to discuss the day’s events.

 

Also in focus: Nasdaq 20K and the key tech names to watch heading into 2025, plus what Tesla’s rally means for Elon Musk’s record-breaking wealth

 

Squawk on the Street Disclaimer

SOTS 2nd Hour: President-Elect Trump visits the New York Stock Exchange; Nasdaq 20K 12/12/24

David Faber and Jim Cramer discuss the massive surge for stocks. Multiple reports emerging saying dexamethasone, a widely available drug, can help critically ill coronavirus patients. The treatment reportedly reduced Covid-19 deaths in hospitalized patients by up to one third. Another piece of the market puzzle, the government reporting a record 17.7% increase in retail sales for May. An IPO over at the Nasdaq, Royalty Pharma, the CEO joining the “Squawk on the Street” gang ahead of its opening trade. Plus, David’s reporting on SoftBank. Sources telling him the company plans to sell up to two-thirds of its stake in T-Mobile early next week valuing the transaction at about $20 billion.

Market Surge, Treatment Hopes, Retail Sales, Royalty Pharma CEO, SoftBank’s T-Mobile Stake

Lyt når som helst, hvor som helst

Other podcasts you might like ...